insights_auto
Why is GH down ६.४१%?
Dive Deeperchevron_right
GH:BMV
Guardant Health Inc
MX$ २,७८४.००
arrow_downward
-६.४१%(-१९०.७१) 1D
अगस्ट ३, १०:३६:०६ GMT-६ · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Mkt. cap
२२.२६ अरब
Avg. vol.
०.००
Volume
०.००
52-wk high
MX$ ३,३९५.१०
52-wk low
MX$ १,१५८.७४
No. of employees
२ हजार
Mkt. cap
२२.२६ अरब
Avg. vol.
०.००
Volume
०.००
52-wk high
MX$ ३,३९५.१०
52-wk low
MX$ १,१५८.७४
No. of employees
२ हजार
News stories
From web sources and news partners
Investing.com
·
१२ घण्टा पहिले
Guardant Health director Alex M. Azar II sells $11,032 in stock
Investing.com UK
·
१४ घण्टा पहिले
PTAB upholds University of Washington patent against Guardant challenge By Investing.com
Stock Titan
·
२२ घण्टा पहिले
A colon cancer blood test had 99% screening follow-through at two rural clinics
Stock Titan
·
१ दिन पहिले
A director proposes selling 69 Guardant Health (GH) shares valued at $11,032.
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees२.५ हजार
Founded२०१२
HeadquartersPalo Alto, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteguardanthealth.com